Market Currents
Merck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that...
-
Thursday, December 13, 2012, 8:22 AM ETMerck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that proposals to put "additional price controls on drugs" could "take away much of the incentive in the capital markets to invest in research and development." The Democrats have proposed reducing soaring medical costs by using Medicare to negotiate lower drug prices.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
